Keros Therapeutics updates corporate presentation for investor meetings

Keros Therapeutics, Inc.

Presentation dated January 2025 posted on company website and attached as Exhibit 99.1.
No specific financial or clinical data disclosed in the furnished exhibit excerpt.
Update is procedural for routine investor communications; no material news identified.

item 7.01 item 9.01

Keros Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001664710-25-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.